Skip to content
The Nexus
HEALTHJul 30 · 19:03 UTCSTAT NEWSAllison DeAngelis, Adam Feuerstein,and Elaine Chen

Capricor’s data clash and a fugitive in the C-suite

The article discusses the FDA's inconsistent approaches to Duchenne muscular dystrophy drugs, potential changes in drug company leadership, and Adam's conversation with a recruiter. It references a podcast episode exploring these topics.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Food and Drug AdministrationorganizationCapricororganizationDuchenne muscular dystrophytopicAdamperson
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting